Quarterly report pursuant to Section 13 or 15(d)

Recent Accounting Pronouncements

v3.23.3
Recent Accounting Pronouncements
9 Months Ended
Sep. 30, 2023
Recent Accounting Pronouncements  
Recent Accounting Pronouncements

Note 13 – Recent Accounting Pronouncements

 

All recent accounting standards issued by the FASB, including its Emerging Issues Task Force, the American Institute of Certified Public Accountants, and the SEC did not or are not believed by management to have a material impact on the Company’s consolidated financial statements.

 

 

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.

 

SPECIAL NOTE CONCERNING FORWARD-LOOKING STATEMENTS

 

Certain statements made in this Form 10-Q are “forward-looking statements.” These statements involve known and unknown risks, uncertainties and other factors which may cause our actual results, performance, or achievements to be materially different from any future results, performances or achievements expressed or implied by the forward-looking statements. We use the words “anticipate”, “believe”, “could”, “design”, “estimate”, “expect”, “intend”, “forecast”, “goal”, “may”, “plan”, “potential”, “predict”, “project”, “should”, “target,” “will,” “would” or the negatives or other tense of such terms and other similar expressions intended to identify forward-looking statements. Forward-looking statements relate to future events or future financial performance and involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance, or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements.

 

Our actual results could differ materially from those discussed in the forward-looking statements. Factors that could cause or contribute to such differences include but are not limited to those contained in the “Risk Factors” section of our Annual Report on Form 10-K and in our subsequent filings with the Securities and Exchange Commission.

 

Management’s Discussion and Analysis of Financial Condition and Results of Operations

 

The following is a discussion of the financial condition and results of operation of InnovaQor as of the date of this Form 10-Q. This discussion and analysis should be read in conjunction with InnovaQor’s audited consolidated financial statements contained in the Form 10-K and with our unaudited condensed consolidated financial statements, including the notes thereto, which are included elsewhere in this report.

 

Estimates

 

Management’s discussion and analysis of InnovaQor’s financial condition and results of operations are based upon its consolidated financial statements, which have been prepared in accordance with U.S. GAAP. The preparation of these financial statements requires management to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses, and the related disclosure of contingent liabilities. Significant areas of estimation include estimating fair value of intangible assets acquired, the impairment of assets, accrued and contingent liabilities, and future income tax obligations (benefits), among other items. On an on-going basis, management evaluates past estimates and judgments, including those related to bad debts, accrued liabilities, derivative liabilities, and contingencies. Management bases its estimates on historical experience and on various other assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions. InnovaQor believes the following critical accounting policies affect its more significant judgments and estimates used in the preparation of its consolidated financial statements.

 

Critical Accounting Policies

 

Basis of Presentation and Principles of Consolidation

 

The acquisition of an operating company by a non-operating public shell corporation typically results in the owners and management of the operating company having actual or effective voting and operating control of the combined company. The Securities and Exchange Commission staff considers a public shell reverse acquisition to be a capital transaction in substance, rather than a business combination. That is, the transaction is a reverse recapitalization, equivalent to the issuance of stock by the operating company for the net monetary assets of the shell corporation accompanied by a recapitalization. The accounting is similar to that resulting from a reverse acquisition, except that no goodwill or other intangible assets are recorded.

 

 

The condensed consolidated financial statements include the accounts of only the HTS Group (the accounting acquirer) prior to June 25, 2021 and InnovaQor and the Group since the date of acquisition on June 25, 2021, with the transaction being accounted for as a recapitalization of the Group on June 25, 2021. The condensed consolidated financial statements are prepared in conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP”) and require management to make certain judgments, estimates, and assumptions. These may affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements. They also may affect the reported amounts of revenues and expenses during the reporting periods. Actual results could differ from those estimates upon subsequent resolution of identified matters.

 

The accompanying condensed consolidated financial statements as of and for the nine and three months ended September 30, 2023 and 2022, have been derived from unaudited financial information. Intercompany accounts and transactions have been eliminated. The accompanying unaudited interim condensed consolidated financial statements have been prepared on the same basis as the annual audited financial statements and in accordance with U.S. GAAP, for interim financial information and the rules and regulations of the Securities and Exchange Commission (“SEC”) for interim financial statements. In the opinion of management, such unaudited information includes all adjustments (consisting only of normal recurring accruals) necessary for a fair presentation of this interim information.

 

Cash and Cash Equivalents

 

InnovaQor considers all highly liquid temporary cash investments with an original maturity of three months or less to be cash equivalents.

 

Fair Value Measurements

 

In accordance with ASC 820, “Fair Value Measurements and Disclosures,” the Company applies fair value accounting for all financial assets and liabilities and non-financial assets and liabilities that are recognized or disclosed at fair value in the financial statements on a recurring basis. Fair value is defined as the price that would be received from selling an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. When determining the fair value measurements for assets and liabilities that are required to be recorded at fair value, the Company considers the principal or most advantageous market in which it would transact and the market-based risk measurements or assumptions that market participants would use in pricing the asset or liability, such as risks inherent in valuation techniques, transfer restrictions and credit risk. Fair value is estimated by applying the following hierarchy, which prioritizes the inputs used to measure fair value into three levels and bases the categorization within the hierarchy upon the lowest level of input that is available and significant to the fair value measurement:

 

  Level 1 applies to assets or liabilities for which there are quoted prices in active markets for identical assets or liabilities that the Company has the ability to access at the measurement date.
     
  Level 2 applies to assets or liabilities for which there are inputs other than quoted prices included in Level 1 that are observable for the asset or liability, either directly or indirectly, such as quoted prices for similar assets or liabilities in active markets; or quoted prices for identical assets or liabilities in markets with insufficient volume or infrequent transactions (less active markets).
     
  Level 3 applies to assets or liabilities for which fair value is derived from valuation techniques in which one or more significant inputs are unobservable, including the Company’s own assumptions.

 

The estimated fair value of financial instruments is determined by the Company using available market information and valuation methodologies considered to be appropriate. At September 30, 2023 and December 31, 2022, the carrying value of the Company’s accounts receivable, accounts payable, accrued expenses and notes payable, approximate their fair values due to their short-term nature. For the nine months ended September 30, 2023 and 2022, there were no realized and unrealized gains on instruments valued using fair value evaluation methods.

 

 

Impairment of Long-lived Assets

 

The Company accounts for the impairment or disposal of long-lived assets according to the Financial Accounting Standards Board’s (“FASB”) ASC 360, “Property, Plant and Equipment.” Long-lived assets are reviewed when facts and circumstances indicate that the carrying value of the asset may not be recoverable. When necessary, impaired assets are written down to estimated fair value based on the best information available. Estimated fair value is generally either based on appraised value or measured by discounting estimated future cash flows. Considerable management judgment is necessary to estimate discounted future cash flows. Accordingly, actual results could vary significantly from such estimates. As of September 30, 2023 and December 31, 2022, all of the Company’s fixed assets were fully depreciated and, therefore, the carrying value of fixed assets represented fair value. Fixed assets are depreciated over lives ranging from three to seven years.

 

Income Taxes

 

The entities within the Group were included in the consolidated income tax returns of its Parent for the years ended December 31, 2020 and prior. A determination was made by Parent’s management not to allocate any of the deferred tax assets or liabilities to the Group as of December 31, 2020 and prior. Accordingly, the Group did not provide for income taxes in the combined financial statements. The Company since June 25, 2021 uses the liability method of accounting for income taxes. Under the liability method, future tax liabilities and assets are recognized for the estimated future tax consequences attributable to differences between the amounts reported in the financial statement carrying amounts of assets and liabilities and their respective tax bases. Future tax assets and liabilities are measured using enacted or substantially enacted income tax rates expected to apply when the asset is realized or the liability settled. The effect of a change in income tax rates on future income tax liabilities and assets is recognized in income in the period that the change occurs. Future income tax assets are recognized to the extent that they are considered more likely than not to be realized. When projected future taxable income is insufficient to provide for the realization of deferred tax assets, the Company will recognize a valuation allowance.

 

In accordance with U.S. GAAP, the Company has determined whether a tax position of the Company is more likely than not to be sustained upon examination by the applicable taxing authority, including resolution of any related appeals or litigation processes, based on the technical merits of the position. The tax benefit to be recognized is measured as the largest amount of benefit that is greater than fifty percent likely of being realized upon ultimate settlement. Derecognition of a tax benefit previously recognized could result in the Company recording a tax liability that would reduce net assets. The Company has determined that it has not incurred any liability for tax benefits as of September 30, 2023 and 2022. State income taxes will also be due on any income generated in the future.

 

Revenue Recognition

 

We recognize revenue in accordance with ASC Topic 606, including subsequently issued updates. This series of comprehensive guidance has replaced all existing revenue recognition guidance. There is a five-step approach outlined in the standard. In determining revenue, we first identify the contract according to the scope of ASU Topic 606 with the following criteria:

 

  Identify the contract(s) with a customer.
     
  Identify the performance obligations in the contract.
     
  Determine the transaction price.
     
  Allocate the transaction price to the performance obligations in the contract.
     
  Recognize revenue when or as you satisfy a performance obligation.

 

 

Revenue is recognized when control of the promised services is transferred to the Company’s customers in an amount that reflects the consideration the Company is expected to be entitled to in exchange for those services. As the Company completes its performance obligations which are identified in Note 10 to the unaudited Condensed Consolidated Financial Statements included herein, it has an unconditional right to consideration as outlined in the Company’s contracts. Generally, the Company’s accounts receivable are expected to be collected in 30 days in accordance with the underlying payment terms. For many of the Company’s services, the Company typically has one performance obligation; however, it also provides the customer with an option to acquire additional services. The Company typically provides a menu of offerings from which the customer may choose to purchase. The price of each service is generally based upon an agreed hourly rate.

 

Convertible Preferred Stock

 

The Company classifies its Series B-1 and Series C-1 Convertible Preferred Stock as liabilities in accordance with ASC 480 Distinguishing Liabilities from Equity since the preferred stock is convertible, at the option of the holder, into a variable number of shares based solely on a fixed dollar amount (stated value) known at issuance of the preferred stock.

 

Basic and Diluted Net Income (Loss) Per Share

 

The Company computes net income (loss) per share in accordance with ASC Topic 260, “Earnings per Share” which requires presentation of both basic and diluted earnings per share (EPS) on the face of the income statement. Basic EPS is computed by dividing net income (loss) available to common shareholders (numerator) by the weighted average number of shares outstanding (denominator) during the period. Diluted EPS gives effect to all dilutive potential common shares outstanding during the period including stock options, using the treasury stock method, and convertible preferred stock, using the if-converted method. As of September 30, 2023 and 2022, there were approximately 2,546,000,000 and 1,671,000,000 common stock equivalents, respectively, which were  antidilutive due to the Company’s losses.

 

Recent Accounting Pronouncements

 

All recent accounting standards issued by the FASB, including its Emerging Issues Task Force, the American Institute of Certified Public Accountants, and the SEC did not or are not believed by management to have a material impact on the Company’s consolidated financial statements.

 

Results of Operations

 

Financial Presentation

 

The following sets forth a discussion and analysis of InnovaQor’s consolidated financial condition and results of operations as of and for the three and nine months ended September  30, 2023 and 2022. This discussion and analysis should be read in conjunction with our consolidated financial statements appearing elsewhere in this filing. The following discussion contains forward-looking statements. Our actual results may differ significantly from the results discussed in such forward-looking statements. Factors that could cause or contribute to such differences include, but are not limited to, those discussed in “Risk Factors” of our Form 10-K.

 

Comparison of the Three Months Ended September 30, 2023 and 2022

 

The following summary of our condensed consolidated results of operations should be read in conjunction with our interim consolidated financial statements as of and for the three months ended September 30, 2023, and 2022, which are included herein.

 

The following table summarizes the results of our consolidated operations for the three months ended September 30, 2023 and 2022 (unaudited):

 

   

Three Months Ended

September 30,

       
    2023     2022     Change  
                   
Net revenues   $ 151,810     $ 78,027     $ 73,783  
Operating expenses:                        
Direct costs of revenue     121,360       32,245       89,115  
General and administrative expenses     377,210       332,657       44,553  
Total operating expenses     498,570       364,902       133,668  
Loss from operations     (346,760 )     (286,875 )     (59,885 )
Other income (expense)     7,955       (46,153 )     54,108  
Loss before income taxes     (338,805 )     (333,028 )     (5,777 )
Provision for income taxes                  
Net loss   $ (338,805 )   $ (333,028 )   $ (5,777 )

 

Net Revenues

 

Net revenues were $151,810 and $78,027 for the three months ended September 30, 2023, and 2022, respectively. The increased revenues were a result of increased prices, new features and one time revenue recognition from existing customers.

 

Direct Costs of Revenue

 

Direct costs of revenue increased by $89,115 compared to the three months ended September 30, 2022, principally due to an increase in operating payroll expenses.

 

General and Administrative Expenses

 

General and administrative expenses increased by $44,553 compared to the three months ended September 30, 2022, principally due to increases in professional and consultant fees.

 

Loss from Operations

 

Our operating loss increased by $59,885 for the three months ended September 30, 2023, when compared to a loss of $(286,875) for the same period last year. The increase was due principally to an increase in administrative costs and direct operating costs.

 

Net Loss

 

Our net loss was $(338,805) for the three months ended September 30, 2023, as compared to a net loss of $(333,028) for the three months ended September 30, 2022. The $5,777 increase in net loss was principally due to a small increase in our payroll expenses.

 

 

Comparison of the Nine months Ended September 30, 2023 and 2022

 

The following summary of our condensed consolidated results of operations should be read in conjunction with our interim consolidated financial statements as of and for the nine months ended September 30, 2023, and 2022, which are included herein.

 

The following table summarizes the results of our consolidated operations for the nine months ended September 30, 2023 and 2022 (unaudited):

 

    Nine Months Ended September 30,        
    2023     2022     Change  
Net revenues   $ 474,770     $ 268,430     $ 206,340  
Operating expenses:                        
Direct costs of revenue     438,654       288,101       150,552  
General and administrative expenses     1,264,930       853,515       414,415  
Total operating expenses     1,703,584       1,141,617       561,967  
Loss from operations     (1,228,814 )     (873,187 )     (355,627 )
Other (expense)     (221,051 )     (66,351 )     (154,700 )
Loss before income taxes     (1,449,865 )     (939,538 )     (510,327 )
Provision for income taxes                  
Net loss   $ (1,449,865 )   $ (939,538 )   $ (510,327 )

 

Net Revenues

 

Net revenues were $474,770 and $268,430 for the nine months ended September 30, 2023, and 2022, respectively. The increased revenues were a result of increased prices, new features and revenue from existing customers.

 

Direct Costs of Revenue

 

Direct costs of revenue increased by $150,552 compared to the nine months ended September 30, 2022, principally due to an increase in payroll and related expenses.

 

General and Administrative Expenses

 

General and administrative expenses increased by $414,415 compared to the nine months ended September 30, 2022, principally due to increases in professional and consultant fees.

 

Loss from Operations

 

Our operating loss increased by $(561,967) for the nine months ended September 30, 2023, when compared to a loss of $(873,187) for the same period last year. The increase was due principally to an increase in our general and administrative expenses.

 

Net Loss

 

Our net loss was $1,449,865 for the nine months ended September 30, 2023, as compared to a net loss of $939,538 for the nine months ended September 30, 2022.

 

The $510,327 increase in net loss was principally due to the increase in our general and administrative expenses and professional and consulting fees.

 

Liquidity and Capital Resources

 

As of September 30, 2023, we had $47,512 in total assets including cash and cash equivalents of $13,695, as compared to $41,641 in total assets including cash and cash equivalents of $5,415 as of December 31, 2022. The increase in total assets is primarily attributable to the increase in Cash and Accounts Receivable.

 

As of September 30, 2023, we had total liabilities of $15,160,221 including accounts payable of $1,531,372, accrued expenses of $1,587,992, related party advances of 1,008,832, notes payable of $1,704,268, and Preferred Stock liabilities of $9,334,757. As of September 30, 2022, we had total liabilities of $13,734,485 including accounts payable of $1,239,945, accrued expenses of $1,638,071, notes payable of $1,632,823 and Preferred Stock liabilities of $9,223,646. The increase is mainly due to an increase in accounts payable and related party advances to fund the operations.

 

 

Cash Flow from Operating Activities

 

Net cash used in operations for the nine months ended September 30, 2023, was $934,346 as compared to $663,958 for the nine months ended September 30, 2022. The increased use of cash was mostly attributed to payroll for the nine months ended September 30, 2023.

 

Cash Flow from Investing Activities

 

Net cash used in investing activities for the nine months ended September 30, 2023 and 2022, was $0.

 

Cash Flow from Financing Activities

 

Net cash provided by financing activities for the nine months ended September 30, 2023, was $942,626 as compared to $667,072 for the nine months ended September 30, 2022. The increase was due to additional advances from the former Parent in the nine months ended September 30, 2023.

 

There are no off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on our financial condition, changes in financial condition, revenues, expenses, results of operations, liquidity, capital expenditures or capital resources.

 

Capitalization

 

The following table sets forth InnovaQor’s capitalization as of September 30, 2023, and December 31, 2022, on an historical basis. In addition, it is not indicative of our future capitalization. This table should be read in conjunction with InnovaQor’s financial statements and notes thereto included elsewhere herein.

 

The following table sets forth our cash and capitalization as of September 30, 2023, and December 31, 2022:

 

    September 30,     December 31,  
    2023     2022  
Cash   $ 13,695     $ 5,415  
                 
Stockholders’ Equity                
Preferred Series A-1 Stock, Par Value $0.0001, 1,000 shares authorized, 1,000 shares issued and outstanding            
Preferred Series D Stock, Par Value $0.0001 and stated value $100, 500 shares authorized, 300 shares issued and outstanding September 30, 2023     30,000        
Common stock, Par Value $0.0001, 2,000,000,000 shares authorized, 244,953,286 issued and outstanding     24,495       24,495  
                 
Additional Paid-in Capital     5,906,742       5,906,742  
Total capitalization   $ 5,974,935     $ 5,936,652  

 

Item 3. Quantitative and Qualitative Disclosures About Market Risk.

 

Not applicable

 

Item 4. Controls and Procedures.

 

Management does not expect that its internal controls over financial reporting will prevent all errors and all fraud. Control systems, no matter how well conceived and managed, can provide only reasonable assurance that the objectives of the control system are met. The design of a control system must reflect the fact that there are resource constraints, and the benefits of controls must be considered relative to their costs. Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, within the Company have been detected. These inherent limitations include that judgments in decision-making can be faulty, and that breakdowns can occur because of simple error or mistake.

 

Additionally, controls can be circumvented by the individual acts of some persons, by collusion of two or more people, or by management override of the control. The design of any system of controls also is based in part upon certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions; over time, control may become inadequate because of changes in conditions, or the degree of compliance with the policies or procedures may deteriorate. Because of the inherent limitations in a cost-effective control system, misstatements due to error or fraud may occur and not be detected.

 

 

Evaluation of Disclosure Controls and Procedures

 

Under the supervision and with the participation of management, including the principal executive officer and principal financial officer, as of September 30, 2023 the Company conducted an evaluation of its disclosure controls and procedures, as such term is defined under Rule 13a-15(e) and Rule 15d-15(e) promulgated under the Securities Exchange Act of 1934, as amended. Based on this evaluation, the principal executive officer and principal financial officer have concluded that, based on the material weaknesses discussed below, the disclosure controls and procedures were not effective as of such date to ensure that information required to be disclosed by the Company in reports filed or submitted under the Securities Exchange Act were recorded, processed, summarized, and reported within the time periods specified in the Securities and Exchange Commission’s rules and forms and that its disclosure controls are not effectively designed to ensure that information required to be disclosed in the reports that the Company files or submits under the Securities Exchange Act is accumulated and communicated to management, including the principal executive officer and principal financial officer, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure.

 

The Company’s internal controls are not effective for the following reasons, (1) there are no entity level controls, because of the limited time of the Company’s officers, (2) there is no separate audit committee, and (3) the Company has not implemented adequate system and manual controls. As a result, the Company’s internal controls have inherent weaknesses, which may increase the risks of errors in financial reporting under current operations and accordingly are not effective as evaluated against the criteria set forth in the Internal Control – Integrated Framework issued by the committee of Sponsoring Organizations of the Treadway Commission (2013 version). Based on the evaluation, management concluded that the Company’s internal controls over financial reporting were not effective as of September 30, 2023.

 

Even though there are inherent weaknesses, management has taken steps to minimize the risk. The Company uses a third-party consultant CFO to review transactions for appropriate technical accounting, reconcile accounts, review significant transactions and prepare financial statements. Any deviation or errors are reported to management.

 

The Company can provide no assurance that its internal controls over financial reporting will be compliant in the near future. As revenues permit, the Company will enhance its internal controls through additional software and other means. If and when it obtains funding, the Company will create an audit committee comprised of independent directors.

 

Changes in Internal Control over Financial Reporting

 

There have been no changes in the Company’s internal control over financial reporting during the last quarterly period covered by this report that have materially affected, or are likely to affect, the internal control over financial reporting.

 

PART II – OTHER INFORMATION

 

Item 1. Legal Proceedings.

 

From time to time, InnovaQor may be involved in a variety of claims, lawsuits, investigations and proceedings related to contractual disputes, employment matters, regulatory and compliance matters, intellectual property rights and other litigation arising in the ordinary course of business. InnovaQor operates in a highly regulated industry which may inherently lend itself to legal matters. Management is aware that litigation has associated costs and that results of adverse litigation verdicts could have a material effect on InnovaQor’s consolidated financial position or results of operations. Management, in consultation with legal counsel, has addressed known assertions and predicted unasserted claims below.

 

P2P Staffing Corp. received a judgment against HTS during 2018 in the amount of $58,784 plus accrued interest and court costs for amounts owed. As of September 30, 2023 and December 31, 2022, $10,464 was outstanding and owed for this judgment and included in accounts payable at each respective balance sheet date.

 

Two former employees of CollabRx, Inc., one of the acquired subsidiaries, filed suits in a California state court against the former Parent, Rennova and CollabRx, Inc., in connection with amounts claimed to be owed under their respective employment agreements with CollabRx, Inc. One former employee received a judgment for approximately $253,000, which Rennova has paid in full. The other former employee received a judgment for approximately $173,000.

 

 

Item 1A. Risk Factors.

 

In addition to the other information set forth in this report, you should carefully consider the risk factors discussed in Part I, Item 1A of the Form 10-K which could materially affect our business, financial condition, or future results. There have been no material changes to the risk factors previously disclosed in our Form 10-K.

 

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.

 

None.

 

Item 3. Defaults Upon Senior Securities.

 

None.

 

Item 4. Mine Safety Disclosures.

 

Not applicable.

 

Item 5. Other Information.

 

Covid Matters

 

The occurrence of an uncontrollable event such as the COVID-19 pandemic did not materially affect our operations since we had rotated to a remote model for our employees well before the COVID-19 event occurred. The pandemic resulted in social distancing, travel bans and quarantines. This limited access to our facilities, customers, management, support staff and professional advisors. These, in turn however, did not impact our operations and financial condition.

 

While the pandemic phase of COVID-19 has receded and the virus is now considered to be endemic in the United States as of this filing, the evolution of an acute and more contagious variant is possible. In such a case, it may impact demand for our products and may again hamper our efforts to provide our investors with timely information and comply with our filing obligations with the Securities and Exchange Commission.

 

Real GDP growth, inflation, employment levels, oil prices, interest rates, tax rates, availability of customer financing, foreign currency exchange rate fluctuations, and other macroeconomic trends can adversely affect demand for the products that we offer. Geopolitical issues around the world and how our markets are positioned can also impact macroeconomic conditions and could have a material adverse impact on our financial results.

 

Item 6. Exhibits

 

10.1   Promissory Note of InnovaQor, Inc., dated July 1, 2022, payable to Rennova Health, Inc.*
     
10.2   Promissory Note of InnovaQor, Inc., dated December 31, 2022, payable to Rennova Health, Inc.*
     
31.1   Rule 13a-14(a) Certification by the Principal Executive Officer.*
     
31.2   Rule 13a-14(a) Certification by the Principal Financial Officer.*
     
32.1   Certification by the Principal Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.**
     
32.2   Certification by the Principal Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.**
     
101.INS   Inline XBRL Instance Document
     
101.SCH   Inline XBRL Schema Document
     
101.CAL   Inline XBRL Calculation Link base Document
     
101.DEF   Inline XBRL Definition Link base Document
     
101.LAB   Inline XBRL Label Link base Document
     
101.PRE   Inline XBRL Presentation Link base Document
     
104   Cover Page Interactive Data File (embedded within the Inline XBRL document)

 

* Filed herewith
   
** Furnished herewith

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

  INNOVAQOR, INC.
     
Date: November 20, 2023 By: /s/ Darrell Peterson
    Darrell Peterson
    Chief Executive Officer
    (Principal Executive Officer)
     
  By: /s/ Thomas J. Bellante
    Thomas J. Bellante
    Chief Financial Officer
    (Principal Financial Officer)